The global Pharmaceutical Testing Services market size is predicted to grow from US$ 4535 million in 2025 to US$ 8433 million in 2031; it is expected to grow at a CAGR of 10.9% from 2025 to 2031.
Pharmaceutical Testing Service is often used to identify the chemical composition and molecular structure of each individual substance contained in a medication.
This knowledge provides insight into a drug"s performance and safety considerations. Pharmaceutical testing can reveal a pharmaceutical"s solubility and can predict the medication"s ability to reach a specific target within the body. Testing may even reveal contamination in the manufacturing production process or highlight other, previously unknown risks with the formulation.
Pharmaceutical Testing Services include raw materials testing, in-process and product release testing, finished pharmaceutical products testing and environmental samples, etc. It is mainly used in analytical testing, method development, stability testing and so on, the end users are like pharmaceutical factory, medical institution, government of health department, etc.
Eurofins, WuXi AppTec, Pace Analytical Services, Catalent, Envigo, PPD, Element (Exova), ALS Pharmaceutical, Intertek Group, SGS, Boston Analytical and EAG are the key manufacturters of Pharmaceutical Testing Services. Eurofins is the leader of it by 21% market shares.
USA market took up about 39% the global market, while EU and China were about 3%, 8%.
The 鈥淧harmaceutical Testing Services Industry Forecast鈥� looks at past sales and reviews total world Pharmaceutical Testing Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Testing Services sales for 2025 through 2031. With Pharmaceutical Testing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Testing Services industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Testing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical Testing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharmaceutical Testing Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Testing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Testing Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Testing Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Raw Materials Testing
In-Process and Product Release Testing
Finished Pharmaceutical Products Testing
Environmental Samples
Others
Segmentation by Application:
Analytical Testing
Method Development
Stability Testing
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eurofins
WuXi AppTec
Pace Analytical Services
Catalent
Envigo
PPD
Element (Exova)
ALS Pharmaceutical
Intertek Group
SGS
Boston Analytical
EAG
DYNALABS
Maxxam
ARLBioPharma
West Pharmaceutical
BioScreen
Microbac
RD Laboratories
Analytical Lab Group
Piramal Pharma Solutions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Pharmaceutical Testing Services 麻豆原创 Size (2020-2031)
2.1.2 Pharmaceutical Testing Services 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Pharmaceutical Testing Services by Country/Region (2020, 2024 & 2031)
2.2 Pharmaceutical Testing Services Segment by Type
2.2.1 Raw Materials Testing
2.2.2 In-Process and Product Release Testing
2.2.3 Finished Pharmaceutical Products Testing
2.2.4 Environmental Samples
2.2.5 Others
2.3 Pharmaceutical Testing Services 麻豆原创 Size by Type
2.3.1 Pharmaceutical Testing Services 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Pharmaceutical Testing Services 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Pharmaceutical Testing Services Segment by Application
2.4.1 Analytical Testing
2.4.2 Method Development
2.4.3 Stability Testing
2.5 Pharmaceutical Testing Services 麻豆原创 Size by Application
2.5.1 Pharmaceutical Testing Services 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Pharmaceutical Testing Services 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Pharmaceutical Testing Services 麻豆原创 Size by Player
3.1 Pharmaceutical Testing Services 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Pharmaceutical Testing Services Revenue by Player (2020-2025)
3.1.2 Global Pharmaceutical Testing Services Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Pharmaceutical Testing Services Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Testing Services by Region
4.1 Pharmaceutical Testing Services 麻豆原创 Size by Region (2020-2025)
4.2 Global Pharmaceutical Testing Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmaceutical Testing Services 麻豆原创 Size Growth (2020-2025)
4.4 APAC Pharmaceutical Testing Services 麻豆原创 Size Growth (2020-2025)
4.5 Europe Pharmaceutical Testing Services 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Pharmaceutical Testing Services 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Pharmaceutical Testing Services 麻豆原创 Size by Country (2020-2025)
5.2 Americas Pharmaceutical Testing Services 麻豆原创 Size by Type (2020-2025)
5.3 Americas Pharmaceutical Testing Services 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Testing Services 麻豆原创 Size by Region (2020-2025)
6.2 APAC Pharmaceutical Testing Services 麻豆原创 Size by Type (2020-2025)
6.3 APAC Pharmaceutical Testing Services 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Testing Services 麻豆原创 Size by Country (2020-2025)
7.2 Europe Pharmaceutical Testing Services 麻豆原创 Size by Type (2020-2025)
7.3 Europe Pharmaceutical Testing Services 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Testing Services by Region (2020-2025)
8.2 Middle East & Africa Pharmaceutical Testing Services 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Pharmaceutical Testing Services 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical Testing Services 麻豆原创 Forecast
10.1 Global Pharmaceutical Testing Services Forecast by Region (2026-2031)
10.1.1 Global Pharmaceutical Testing Services Forecast by Region (2026-2031)
10.1.2 Americas Pharmaceutical Testing Services Forecast
10.1.3 APAC Pharmaceutical Testing Services Forecast
10.1.4 Europe Pharmaceutical Testing Services Forecast
10.1.5 Middle East & Africa Pharmaceutical Testing Services Forecast
10.2 Americas Pharmaceutical Testing Services Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Pharmaceutical Testing Services Forecast
10.2.2 Canada 麻豆原创 Pharmaceutical Testing Services Forecast
10.2.3 Mexico 麻豆原创 Pharmaceutical Testing Services Forecast
10.2.4 Brazil 麻豆原创 Pharmaceutical Testing Services Forecast
10.3 APAC Pharmaceutical Testing Services Forecast by Region (2026-2031)
10.3.1 China Pharmaceutical Testing Services 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Pharmaceutical Testing Services Forecast
10.3.3 Korea 麻豆原创 Pharmaceutical Testing Services Forecast
10.3.4 Southeast Asia 麻豆原创 Pharmaceutical Testing Services Forecast
10.3.5 India 麻豆原创 Pharmaceutical Testing Services Forecast
10.3.6 Australia 麻豆原创 Pharmaceutical Testing Services Forecast
10.4 Europe Pharmaceutical Testing Services Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Pharmaceutical Testing Services Forecast
10.4.2 France 麻豆原创 Pharmaceutical Testing Services Forecast
10.4.3 UK 麻豆原创 Pharmaceutical Testing Services Forecast
10.4.4 Italy 麻豆原创 Pharmaceutical Testing Services Forecast
10.4.5 Russia 麻豆原创 Pharmaceutical Testing Services Forecast
10.5 Middle East & Africa Pharmaceutical Testing Services Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Pharmaceutical Testing Services Forecast
10.5.2 South Africa 麻豆原创 Pharmaceutical Testing Services Forecast
10.5.3 Israel 麻豆原创 Pharmaceutical Testing Services Forecast
10.5.4 Turkey 麻豆原创 Pharmaceutical Testing Services Forecast
10.6 Global Pharmaceutical Testing Services Forecast by Type (2026-2031)
10.7 Global Pharmaceutical Testing Services Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Pharmaceutical Testing Services Forecast
11 Key Players Analysis
11.1 Eurofins
11.1.1 Eurofins Company Information
11.1.2 Eurofins Pharmaceutical Testing Services Product Offered
11.1.3 Eurofins Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Eurofins Main Business Overview
11.1.5 Eurofins Latest Developments
11.2 WuXi AppTec
11.2.1 WuXi AppTec Company Information
11.2.2 WuXi AppTec Pharmaceutical Testing Services Product Offered
11.2.3 WuXi AppTec Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 WuXi AppTec Main Business Overview
11.2.5 WuXi AppTec Latest Developments
11.3 Pace Analytical Services
11.3.1 Pace Analytical Services Company Information
11.3.2 Pace Analytical Services Pharmaceutical Testing Services Product Offered
11.3.3 Pace Analytical Services Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Pace Analytical Services Main Business Overview
11.3.5 Pace Analytical Services Latest Developments
11.4 Catalent
11.4.1 Catalent Company Information
11.4.2 Catalent Pharmaceutical Testing Services Product Offered
11.4.3 Catalent Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Catalent Main Business Overview
11.4.5 Catalent Latest Developments
11.5 Envigo
11.5.1 Envigo Company Information
11.5.2 Envigo Pharmaceutical Testing Services Product Offered
11.5.3 Envigo Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Envigo Main Business Overview
11.5.5 Envigo Latest Developments
11.6 PPD
11.6.1 PPD Company Information
11.6.2 PPD Pharmaceutical Testing Services Product Offered
11.6.3 PPD Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 PPD Main Business Overview
11.6.5 PPD Latest Developments
11.7 Element (Exova)
11.7.1 Element (Exova) Company Information
11.7.2 Element (Exova) Pharmaceutical Testing Services Product Offered
11.7.3 Element (Exova) Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Element (Exova) Main Business Overview
11.7.5 Element (Exova) Latest Developments
11.8 ALS Pharmaceutical
11.8.1 ALS Pharmaceutical Company Information
11.8.2 ALS Pharmaceutical Pharmaceutical Testing Services Product Offered
11.8.3 ALS Pharmaceutical Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 ALS Pharmaceutical Main Business Overview
11.8.5 ALS Pharmaceutical Latest Developments
11.9 Intertek Group
11.9.1 Intertek Group Company Information
11.9.2 Intertek Group Pharmaceutical Testing Services Product Offered
11.9.3 Intertek Group Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Intertek Group Main Business Overview
11.9.5 Intertek Group Latest Developments
11.10 SGS
11.10.1 SGS Company Information
11.10.2 SGS Pharmaceutical Testing Services Product Offered
11.10.3 SGS Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 SGS Main Business Overview
11.10.5 SGS Latest Developments
11.11 Boston Analytical
11.11.1 Boston Analytical Company Information
11.11.2 Boston Analytical Pharmaceutical Testing Services Product Offered
11.11.3 Boston Analytical Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Boston Analytical Main Business Overview
11.11.5 Boston Analytical Latest Developments
11.12 EAG
11.12.1 EAG Company Information
11.12.2 EAG Pharmaceutical Testing Services Product Offered
11.12.3 EAG Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 EAG Main Business Overview
11.12.5 EAG Latest Developments
11.13 DYNALABS
11.13.1 DYNALABS Company Information
11.13.2 DYNALABS Pharmaceutical Testing Services Product Offered
11.13.3 DYNALABS Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 DYNALABS Main Business Overview
11.13.5 DYNALABS Latest Developments
11.14 Maxxam
11.14.1 Maxxam Company Information
11.14.2 Maxxam Pharmaceutical Testing Services Product Offered
11.14.3 Maxxam Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Maxxam Main Business Overview
11.14.5 Maxxam Latest Developments
11.15 ARLBioPharma
11.15.1 ARLBioPharma Company Information
11.15.2 ARLBioPharma Pharmaceutical Testing Services Product Offered
11.15.3 ARLBioPharma Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 ARLBioPharma Main Business Overview
11.15.5 ARLBioPharma Latest Developments
11.16 West Pharmaceutical
11.16.1 West Pharmaceutical Company Information
11.16.2 West Pharmaceutical Pharmaceutical Testing Services Product Offered
11.16.3 West Pharmaceutical Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 West Pharmaceutical Main Business Overview
11.16.5 West Pharmaceutical Latest Developments
11.17 BioScreen
11.17.1 BioScreen Company Information
11.17.2 BioScreen Pharmaceutical Testing Services Product Offered
11.17.3 BioScreen Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 BioScreen Main Business Overview
11.17.5 BioScreen Latest Developments
11.18 Microbac
11.18.1 Microbac Company Information
11.18.2 Microbac Pharmaceutical Testing Services Product Offered
11.18.3 Microbac Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Microbac Main Business Overview
11.18.5 Microbac Latest Developments
11.19 RD Laboratories
11.19.1 RD Laboratories Company Information
11.19.2 RD Laboratories Pharmaceutical Testing Services Product Offered
11.19.3 RD Laboratories Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.19.4 RD Laboratories Main Business Overview
11.19.5 RD Laboratories Latest Developments
11.20 Analytical Lab Group
11.20.1 Analytical Lab Group Company Information
11.20.2 Analytical Lab Group Pharmaceutical Testing Services Product Offered
11.20.3 Analytical Lab Group Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.20.4 Analytical Lab Group Main Business Overview
11.20.5 Analytical Lab Group Latest Developments
11.21 Piramal Pharma Solutions
11.21.1 Piramal Pharma Solutions Company Information
11.21.2 Piramal Pharma Solutions Pharmaceutical Testing Services Product Offered
11.21.3 Piramal Pharma Solutions Pharmaceutical Testing Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.21.4 Piramal Pharma Solutions Main Business Overview
11.21.5 Piramal Pharma Solutions Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
